Table 2. Data sets for leukemic patients.
| Data set | Organism | Source | Patient numbers | Cell types | Reference |
|---|---|---|---|---|---|
| AML Normal Karyotype data sets | Human AML | GSE15434 | 251 | NK-AML, WBM | Kohlman et al. (28) |
| AML TCGA data sets | Human AML | TCGA | 183 | Various genetic aberrations, including t(8;21), inv(16), t(15;17), t(11q23), complex karyotype, WBM | TCGA (9) |
| Leukemia MILE study | Human AML, ALL, CML, CLL and MDS | GSE13159 | 2096 | AML, ALL and preleukemic stages. | Haferlach et al. (29,30) |
| AML versus normal | Human AML | GSE6891, GSE13159 | 91 | NK-AML, WBM | de Jonge et al. (31,32) |
| 251 | |||||
| Bloodpool | Human AML | GSE13159, GSE15434, TCGA, GSE61804, GSE14468 | 2076 | Mainly AML, ALL and preleukemic stages. | all references above |